<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>10338578</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">37301785</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">10338578</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">3174</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1007/s00234-023-03174-1</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical information by participant group</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>Demographic and clinical information by participant group</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>1. CIS (<italic>n</italic>=24)</th><th>2. RR-MS (<italic>n</italic>=29)</th><th>3. HC (<italic>n</italic>=39)</th><th>1 vs 2</th><th><italic>p</italic> value<break/>1 vs 3</th><th><italic>p</italic> value<break/>2 vs 3</th></tr></thead><tbody><tr><td>Age (years)</td><td>38.3 (8.7)</td><td>38.0 (6.1)</td><td>41.2 (15.1)</td><td>0.9<sup>1</sup></td><td>.2</td><td>.15</td></tr><tr><td>Education (years)</td><td>11.8 (3.1)</td><td>13.3 (3.7)</td><td>14.1 (2.5)</td><td>0.1<sup>1</sup></td><td>.1</td><td>.5</td></tr><tr><td>Females</td><td>20 (83.3%)</td><td>23 (79.3%)</td><td>27 (69%)</td><td>0.8<sup>2</sup></td><td>.3</td><td>.8</td></tr><tr><td>EDSS</td><td>1.3 (0.7)</td><td>3.1 (1.4)</td><td>--</td><td>&lt;0.001<sup>4</sup></td><td>--</td><td>--</td></tr><tr><td> (Range)</td><td>0–2.5</td><td>0.5–6.0</td><td>--</td><td>--</td><td>--</td><td>--</td></tr><tr><td>Illness duration (years)</td><td>4.3 (2.9)</td><td>8.2 (5.6)</td><td>--</td><td>0.002<sup>1</sup></td><td>--</td><td>--</td></tr><tr><td> (Range)</td><td>1–8</td><td>1–15</td><td>--</td><td>--</td><td>--</td><td>--</td></tr><tr><td>Number of relapses</td><td>0</td><td>3.6 (3.7)</td><td>--</td><td>&lt;0.001<sup>4</sup></td><td>--</td><td>--</td></tr><tr><td> (Range)</td><td>-</td><td>0-14</td><td>--</td><td>--</td><td>--</td><td>--</td></tr><tr><td>Total IC volume (cm<sup>3</sup>)</td><td>1333.7 (146.4)</td><td>1356.4 (123.4)</td><td>1387.5 (140.4)</td><td>0.5<sup>1</sup></td><td>.2</td><td>.4</td></tr><tr><td>Total GM volume (cm<sup>3</sup>)</td><td>668.0 (83.0)</td><td>659.9 (62.1)</td><td>684.1 (60.2)</td><td>0.5<sup>3</sup></td><td>.3</td><td>.1</td></tr><tr><td>Total WM volume (cm<sup>3</sup>)</td><td>503.8 (61.0)</td><td>471.9 (70.5)</td><td>499.5 (43.3)</td><td>0.07<sup>3</sup></td><td>.5</td><td>0.06</td></tr><tr><td>Total lesion volume (cm<sup>3</sup>)</td><td>4.5 (6.1)</td><td>11.6 (15.9)</td><td>--</td><td>0.03<sup>3</sup></td><td>--</td><td>--</td></tr></tbody></table><table-wrap-foot><p><italic>EDSS</italic> expanded disability status scale, <italic>HC</italic> healthy controls, <italic>WM</italic> gray matter, <italic>WM</italic> white matter, <italic>IC</italic> intracranial. Unless otherwise indicated, values are group means (SD). <sup>1</sup><italic>t</italic>-test, <sup>2</sup>chi-square test for proportions, <sup>3</sup>one-way ANCOVA controlling for total intracranial volume, <sup>4</sup>Mann–Whitney <italic>U</italic></p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical information by participant group</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>1. CIS (n=24)</th><th>2. RR-MS (n=29)</th><th>3. HC (n=39)</th><th>1 vs 2</th><th>p value1 vs 3</th><th>p value2 vs 3</th></tr></thead><tbody><tr><td>Age (years)</td><td>38.3 (8.7)</td><td>38.0 (6.1)</td><td>41.2 (15.1)</td><td>0.91</td><td>.2</td><td>.15</td></tr><tr><td>Education (years)</td><td>11.8 (3.1)</td><td>13.3 (3.7)</td><td>14.1 (2.5)</td><td>0.11</td><td>.1</td><td>.5</td></tr><tr><td>Females</td><td>20 (83.3%)</td><td>23 (79.3%)</td><td>27 (69%)</td><td>0.82</td><td>.3</td><td>.8</td></tr><tr><td>EDSS</td><td>1.3 (0.7)</td><td>3.1 (1.4)</td><td>--</td><td>&lt;0.0014</td><td>--</td><td>--</td></tr><tr><td> (Range)</td><td>0–2.5</td><td>0.5–6.0</td><td>--</td><td>--</td><td>--</td><td>--</td></tr><tr><td>Illness duration (years)</td><td>4.3 (2.9)</td><td>8.2 (5.6)</td><td>--</td><td>0.0021</td><td>--</td><td>--</td></tr><tr><td> (Range)</td><td>1–8</td><td>1–15</td><td>--</td><td>--</td><td>--</td><td>--</td></tr><tr><td>Number of relapses</td><td>0</td><td>3.6 (3.7)</td><td>--</td><td>&lt;0.0014</td><td>--</td><td>--</td></tr><tr><td> (Range)</td><td>-</td><td>0-14</td><td>--</td><td>--</td><td>--</td><td>--</td></tr><tr><td>Total IC volume (cm3)</td><td>1333.7 (146.4)</td><td>1356.4 (123.4)</td><td>1387.5 (140.4)</td><td>0.51</td><td>.2</td><td>.4</td></tr><tr><td>Total GM volume (cm3)</td><td>668.0 (83.0)</td><td>659.9 (62.1)</td><td>684.1 (60.2)</td><td>0.53</td><td>.3</td><td>.1</td></tr><tr><td>Total WM volume (cm3)</td><td>503.8 (61.0)</td><td>471.9 (70.5)</td><td>499.5 (43.3)</td><td>0.073</td><td>.5</td><td>0.06</td></tr><tr><td>Total lesion volume (cm3)</td><td>4.5 (6.1)</td><td>11.6 (15.9)</td><td>--</td><td>0.033</td><td>--</td><td>--</td></tr></tbody></table></div>EDSS expanded disability status scale, HC healthy controls, WM gray matter, WM white matter, IC intracranial. Unless otherwise indicated, values are group means (SD). 1t-test, 2chi-square test for proportions, 3one-way ANCOVA controlling for total intracranial volume, 4Mann–Whitney U</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Cognitive and emotional status of CIS and RR-MS patients</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2"><label>Table 2</label><caption><p>Cognitive and emotional status of CIS and RR-MS patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">CIS (<italic>n</italic>=24)</th><th colspan="2">RR-MS (<italic>n</italic>=29)</th><th><italic>p</italic> value</th></tr><tr><th>Raw score</th><th><italic>z</italic> score</th><th>Raw score</th><th><italic>z</italic> score</th><th/></tr></thead><tbody><tr><td>AVLT trials 1–5</td><td>55.6 (10.5)</td><td>0.21 (1.1)</td><td>54.2 (10.2)</td><td>−0.12 (1.2)</td><td>0.4<sup>1</sup></td></tr><tr><td>AVLT trial 7</td><td>12.3 (2.3)</td><td>0.58 (1.0)</td><td>11.6 (3.6)</td><td>0.13 (1.3)</td><td>0.2<sup>1</sup></td></tr><tr><td>AVLT retention</td><td>0.95 (0.1)</td><td>0.92 (0.6)</td><td>0.89 (0.1)</td><td>0.30 (0.9)</td><td>0.03<sup>1</sup></td></tr><tr><td>Digit span</td><td>14.3 (2.6)</td><td>−0.45 (0.3)</td><td>13.9 (3.1)</td><td>−0.62 (0.4)</td><td>0.3<sup>1</sup></td></tr><tr><td>SVFT</td><td>50.0 (10.8)</td><td>−0.13 (1.0)</td><td>48.3 (9.5)</td><td>−0.48 (0.9)</td><td>0.2<sup>1</sup></td></tr><tr><td>PhVFT</td><td>28.2 (10.3)</td><td>−0.63 (1.0)</td><td>26.6 (10.2)</td><td>−1.00 (0.8)</td><td>0.1<sup>1</sup></td></tr><tr><td>TMT-A (s)</td><td>28.9 (9.3)</td><td>0.09 (0.6)</td><td>41.0 (29.3)</td><td>−0.83 (1.8)</td><td>0.02<sup>1</sup></td></tr><tr><td>TMT-B (s)</td><td>64.9 (35.5)</td><td>−0.11 (1.9)</td><td>95.2 (70.0)</td><td>−1.22 (2.4)</td><td>0.04<sup>1</sup></td></tr><tr><td>Pegboard (s)</td><td>70.6 (9.1)</td><td>0.66 (1.2)</td><td>104.8 (47.8)</td><td>−5.24 (6.2)</td><td>0.001<sup>1</sup></td></tr><tr><td>WAIS-IV matrices</td><td>21.3 (7.4)</td><td>0.29 (1.1)</td><td>20.0 (6.8)</td><td>−0.21 (1.0)</td><td>0.4<sup>1</sup></td></tr><tr><td>HADS depression</td><td>4.6 (3.1)</td><td>-</td><td>5.8 (2.6)</td><td>-</td><td>0.1<sup>1</sup></td></tr><tr><td>% &gt;8 points</td><td>8.3%</td><td>-</td><td>31.0%</td><td>-</td><td>0.05<sup>2</sup></td></tr><tr><td>FSS</td><td>33.1 (15.9)</td><td>-</td><td>42.6 (15.0)</td><td>-</td><td>0.03<sup>1</sup></td></tr><tr><td>% &gt;36 points</td><td>33.3%</td><td>-</td><td>69.0%</td><td>-</td><td>0.01<sup>2</sup></td></tr></tbody></table><table-wrap-foot><p>Unless otherwise indicated, values correspond to mean (SD). <italic>Z</italic> scores: age- and education-adjusted based on population norms; <italic>AVLT</italic> auditory verbal learning test; <italic>SVFT</italic> semantic verbal fluency test; <italic>PhVFT</italic> phonemic verbal fluency test; <italic>TMT</italic> Trail Making Test; <italic>WAIS-IV</italic> Wechsler Adult Intelligence Scale, Fourth Edition; <italic>FSS</italic> Fatigue Severity Scale; <italic>HADS</italic> Hospital Anxiety and Depression Scale. <sup>1</sup>One-way ANOVA</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Cognitive and emotional status of CIS and RR-MS patients</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">CIS (n=24)</th><th colspan="2">RR-MS (n=29)</th><th>p value</th></tr><tr><th>Raw score</th><th>z score</th><th>Raw score</th><th>z score</th><th/></tr></thead><tbody><tr><td>AVLT trials 1–5</td><td>55.6 (10.5)</td><td>0.21 (1.1)</td><td>54.2 (10.2)</td><td>−0.12 (1.2)</td><td>0.41</td></tr><tr><td>AVLT trial 7</td><td>12.3 (2.3)</td><td>0.58 (1.0)</td><td>11.6 (3.6)</td><td>0.13 (1.3)</td><td>0.21</td></tr><tr><td>AVLT retention</td><td>0.95 (0.1)</td><td>0.92 (0.6)</td><td>0.89 (0.1)</td><td>0.30 (0.9)</td><td>0.031</td></tr><tr><td>Digit span</td><td>14.3 (2.6)</td><td>−0.45 (0.3)</td><td>13.9 (3.1)</td><td>−0.62 (0.4)</td><td>0.31</td></tr><tr><td>SVFT</td><td>50.0 (10.8)</td><td>−0.13 (1.0)</td><td>48.3 (9.5)</td><td>−0.48 (0.9)</td><td>0.21</td></tr><tr><td>PhVFT</td><td>28.2 (10.3)</td><td>−0.63 (1.0)</td><td>26.6 (10.2)</td><td>−1.00 (0.8)</td><td>0.11</td></tr><tr><td>TMT-A (s)</td><td>28.9 (9.3)</td><td>0.09 (0.6)</td><td>41.0 (29.3)</td><td>−0.83 (1.8)</td><td>0.021</td></tr><tr><td>TMT-B (s)</td><td>64.9 (35.5)</td><td>−0.11 (1.9)</td><td>95.2 (70.0)</td><td>−1.22 (2.4)</td><td>0.041</td></tr><tr><td>Pegboard (s)</td><td>70.6 (9.1)</td><td>0.66 (1.2)</td><td>104.8 (47.8)</td><td>−5.24 (6.2)</td><td>0.0011</td></tr><tr><td>WAIS-IV matrices</td><td>21.3 (7.4)</td><td>0.29 (1.1)</td><td>20.0 (6.8)</td><td>−0.21 (1.0)</td><td>0.41</td></tr><tr><td>HADS depression</td><td>4.6 (3.1)</td><td>-</td><td>5.8 (2.6)</td><td>-</td><td>0.11</td></tr><tr><td>% &gt;8 points</td><td>8.3%</td><td>-</td><td>31.0%</td><td>-</td><td>0.052</td></tr><tr><td>FSS</td><td>33.1 (15.9)</td><td>-</td><td>42.6 (15.0)</td><td>-</td><td>0.031</td></tr><tr><td>% &gt;36 points</td><td>33.3%</td><td>-</td><td>69.0%</td><td>-</td><td>0.012</td></tr></tbody></table></div>Unless otherwise indicated, values correspond to mean (SD). Z scores: age- and education-adjusted based on population norms; AVLT auditory verbal learning test; SVFT semantic verbal fluency test; PhVFT phonemic verbal fluency test; TMT Trail Making Test; WAIS-IV Wechsler Adult Intelligence Scale, Fourth Edition; FSS Fatigue Severity Scale; HADS Hospital Anxiety and Depression Scale. 1One-way ANOVA</transformed-table></extracted-table></extracted-tables-set>